Global Equine Pharmaceuticals and Supplements Market Research Report 2024(Status and Outlook)
Report Overview
Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases.
This report provides a deep insight into the global Equine Pharmaceuticals and Supplements market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Equine Pharmaceuticals and Supplements Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Equine Pharmaceuticals and Supplements market in any manner.
Global Equine Pharmaceuticals and Supplements Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Boehringer Ingelheim
Merck Animal Health
Zoetis
Bayer Animal Health
Elanco Animal Health
Dechra Veterinary Products
CEVA
Virbac
Norbrook Equine
Kyoritsu Seiyaku
Vetoquinol
Protexin Healthcare
Audevard
Ouro Fino Saude
Market Segmentation (by Type)
Pharmaceuticals
Supplements
Market Segmentation (by Application)
Thoroughbred Horse
Other Types of Horses
Geographic Segmentation
%li%North America (USA, Canada, Mexico)
%li%Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
%li%Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
%li%South America (Brazil, Argentina, Columbia, Rest of South America)
%li%The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
%li%Industry drivers, restraints, and opportunities covered in the study
%li%Neutral perspective on the market performance
%li%Recent industry trends and developments
%li%Competitive landscape & strategies of key players
%li%Potential & niche segments and regions exhibiting promising growth covered
%li%Historical, current, and projected market size, in terms of value
%li%In-depth analysis of the Equine Pharmaceuticals and Supplements Market
%li%Overview of the regional outlook of the Equine Pharmaceuticals and Supplements Market:
Key Reasons to Buy this Report:
%li%Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
%li%This enables you to anticipate market changes to remain ahead of your competitors
%li%You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
%li%The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
%li%Provision of market value (USD Billion) data for each segment and sub-segment
%li%Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
%li%Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
%li%Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
%li%Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
%li%The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
%li%Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
%li%Provides insight into the market through Value Chain
%li%Market dynamics scenario, along with growth opportunities of the market in the years to come
%li%6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Equine Pharmaceuticals and Supplements Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases.
This report provides a deep insight into the global Equine Pharmaceuticals and Supplements market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Equine Pharmaceuticals and Supplements Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Equine Pharmaceuticals and Supplements market in any manner.
Global Equine Pharmaceuticals and Supplements Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Boehringer Ingelheim
Merck Animal Health
Zoetis
Bayer Animal Health
Elanco Animal Health
Dechra Veterinary Products
CEVA
Virbac
Norbrook Equine
Kyoritsu Seiyaku
Vetoquinol
Protexin Healthcare
Audevard
Ouro Fino Saude
Market Segmentation (by Type)
Pharmaceuticals
Supplements
Market Segmentation (by Application)
Thoroughbred Horse
Other Types of Horses
Geographic Segmentation
%li%North America (USA, Canada, Mexico)
%li%Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
%li%Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
%li%South America (Brazil, Argentina, Columbia, Rest of South America)
%li%The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
%li%Industry drivers, restraints, and opportunities covered in the study
%li%Neutral perspective on the market performance
%li%Recent industry trends and developments
%li%Competitive landscape & strategies of key players
%li%Potential & niche segments and regions exhibiting promising growth covered
%li%Historical, current, and projected market size, in terms of value
%li%In-depth analysis of the Equine Pharmaceuticals and Supplements Market
%li%Overview of the regional outlook of the Equine Pharmaceuticals and Supplements Market:
Key Reasons to Buy this Report:
%li%Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
%li%This enables you to anticipate market changes to remain ahead of your competitors
%li%You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
%li%The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
%li%Provision of market value (USD Billion) data for each segment and sub-segment
%li%Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
%li%Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
%li%Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
%li%Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
%li%The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
%li%Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
%li%Provides insight into the market through Value Chain
%li%Market dynamics scenario, along with growth opportunities of the market in the years to come
%li%6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Equine Pharmaceuticals and Supplements Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Equine Pharmaceuticals and Supplements
1.2 Key Market Segments
1.2.1 Equine Pharmaceuticals and Supplements Segment by Type
1.2.2 Equine Pharmaceuticals and Supplements Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Equine Pharmaceuticals and Supplements Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Equine Pharmaceuticals and Supplements Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET COMPETITIVE LANDSCAPE
3.1 Global Equine Pharmaceuticals and Supplements Sales by Manufacturers (2019-2024)
3.2 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Manufacturers (2019-2024)
3.3 Equine Pharmaceuticals and Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Equine Pharmaceuticals and Supplements Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Equine Pharmaceuticals and Supplements Sales Sites, Area Served, Product Type
3.6 Equine Pharmaceuticals and Supplements Market Competitive Situation and Trends
3.6.1 Equine Pharmaceuticals and Supplements Market Concentration Rate
3.6.2 Global 5 and 10 Largest Equine Pharmaceuticals and Supplements Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 EQUINE PHARMACEUTICALS AND SUPPLEMENTS INDUSTRY CHAIN ANALYSIS
4.1 Equine Pharmaceuticals and Supplements Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2019-2024)
6.3 Global Equine Pharmaceuticals and Supplements Market Size Market Share by Type (2019-2024)
6.4 Global Equine Pharmaceuticals and Supplements Price by Type (2019-2024)
7 EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Equine Pharmaceuticals and Supplements Market Sales by Application (2019-2024)
7.3 Global Equine Pharmaceuticals and Supplements Market Size (M USD) by Application (2019-2024)
7.4 Global Equine Pharmaceuticals and Supplements Sales Growth Rate by Application (2019-2024)
8 EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET SEGMENTATION BY REGION
8.1 Global Equine Pharmaceuticals and Supplements Sales by Region
8.1.1 Global Equine Pharmaceuticals and Supplements Sales by Region
8.1.2 Global Equine Pharmaceuticals and Supplements Sales Market Share by Region
8.2 North America
8.2.1 North America Equine Pharmaceuticals and Supplements Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Equine Pharmaceuticals and Supplements Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Equine Pharmaceuticals and Supplements Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Equine Pharmaceuticals and Supplements Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Boehringer Ingelheim
9.1.1 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Basic Information
9.1.2 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Overview
9.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Market Performance
9.1.4 Boehringer Ingelheim Business Overview
9.1.5 Boehringer Ingelheim Equine Pharmaceuticals and Supplements SWOT Analysis
9.1.6 Boehringer Ingelheim Recent Developments
9.2 Merck Animal Health
9.2.1 Merck Animal Health Equine Pharmaceuticals and Supplements Basic Information
9.2.2 Merck Animal Health Equine Pharmaceuticals and Supplements Product Overview
9.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Product Market Performance
9.2.4 Merck Animal Health Business Overview
9.2.5 Merck Animal Health Equine Pharmaceuticals and Supplements SWOT Analysis
9.2.6 Merck Animal Health Recent Developments
9.3 Zoetis
9.3.1 Zoetis Equine Pharmaceuticals and Supplements Basic Information
9.3.2 Zoetis Equine Pharmaceuticals and Supplements Product Overview
9.3.3 Zoetis Equine Pharmaceuticals and Supplements Product Market Performance
9.3.4 Zoetis Equine Pharmaceuticals and Supplements SWOT Analysis
9.3.5 Zoetis Business Overview
9.3.6 Zoetis Recent Developments
9.4 Bayer Animal Health
9.4.1 Bayer Animal Health Equine Pharmaceuticals and Supplements Basic Information
9.4.2 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Overview
9.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Market Performance
9.4.4 Bayer Animal Health Business Overview
9.4.5 Bayer Animal Health Recent Developments
9.5 Elanco Animal Health
9.5.1 Elanco Animal Health Equine Pharmaceuticals and Supplements Basic Information
9.5.2 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Overview
9.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Market Performance
9.5.4 Elanco Animal Health Business Overview
9.5.5 Elanco Animal Health Recent Developments
9.6 Dechra Veterinary Products
9.6.1 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Basic Information
9.6.2 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Overview
9.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Market Performance
9.6.4 Dechra Veterinary Products Business Overview
9.6.5 Dechra Veterinary Products Recent Developments
9.7 CEVA
9.7.1 CEVA Equine Pharmaceuticals and Supplements Basic Information
9.7.2 CEVA Equine Pharmaceuticals and Supplements Product Overview
9.7.3 CEVA Equine Pharmaceuticals and Supplements Product Market Performance
9.7.4 CEVA Business Overview
9.7.5 CEVA Recent Developments
9.8 Virbac
9.8.1 Virbac Equine Pharmaceuticals and Supplements Basic Information
9.8.2 Virbac Equine Pharmaceuticals and Supplements Product Overview
9.8.3 Virbac Equine Pharmaceuticals and Supplements Product Market Performance
9.8.4 Virbac Business Overview
9.8.5 Virbac Recent Developments
9.9 Norbrook Equine
9.9.1 Norbrook Equine Equine Pharmaceuticals and Supplements Basic Information
9.9.2 Norbrook Equine Equine Pharmaceuticals and Supplements Product Overview
9.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Product Market Performance
9.9.4 Norbrook Equine Business Overview
9.9.5 Norbrook Equine Recent Developments
9.10 Kyoritsu Seiyaku
9.10.1 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Basic Information
9.10.2 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Overview
9.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Market Performance
9.10.4 Kyoritsu Seiyaku Business Overview
9.10.5 Kyoritsu Seiyaku Recent Developments
9.11 Vetoquinol
9.11.1 Vetoquinol Equine Pharmaceuticals and Supplements Basic Information
9.11.2 Vetoquinol Equine Pharmaceuticals and Supplements Product Overview
9.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Product Market Performance
9.11.4 Vetoquinol Business Overview
9.11.5 Vetoquinol Recent Developments
9.12 Protexin Healthcare
9.12.1 Protexin Healthcare Equine Pharmaceuticals and Supplements Basic Information
9.12.2 Protexin Healthcare Equine Pharmaceuticals and Supplements Product Overview
9.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Product Market Performance
9.12.4 Protexin Healthcare Business Overview
9.12.5 Protexin Healthcare Recent Developments
9.13 Audevard
9.13.1 Audevard Equine Pharmaceuticals and Supplements Basic Information
9.13.2 Audevard Equine Pharmaceuticals and Supplements Product Overview
9.13.3 Audevard Equine Pharmaceuticals and Supplements Product Market Performance
9.13.4 Audevard Business Overview
9.13.5 Audevard Recent Developments
9.14 Ouro Fino Saude
9.14.1 Ouro Fino Saude Equine Pharmaceuticals and Supplements Basic Information
9.14.2 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Overview
9.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Market Performance
9.14.4 Ouro Fino Saude Business Overview
9.14.5 Ouro Fino Saude Recent Developments
10 EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET FORECAST BY REGION
10.1 Global Equine Pharmaceuticals and Supplements Market Size Forecast
10.2 Global Equine Pharmaceuticals and Supplements Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Equine Pharmaceuticals and Supplements Market Size Forecast by Country
10.2.3 Asia Pacific Equine Pharmaceuticals and Supplements Market Size Forecast by Region
10.2.4 South America Equine Pharmaceuticals and Supplements Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Equine Pharmaceuticals and Supplements by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Equine Pharmaceuticals and Supplements Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Equine Pharmaceuticals and Supplements by Type (2025-2030)
11.1.2 Global Equine Pharmaceuticals and Supplements Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Equine Pharmaceuticals and Supplements by Type (2025-2030)
11.2 Global Equine Pharmaceuticals and Supplements Market Forecast by Application (2025-2030)
11.2.1 Global Equine Pharmaceuticals and Supplements Sales (Kilotons) Forecast by Application
11.2.2 Global Equine Pharmaceuticals and Supplements Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Equine Pharmaceuticals and Supplements
1.2 Key Market Segments
1.2.1 Equine Pharmaceuticals and Supplements Segment by Type
1.2.2 Equine Pharmaceuticals and Supplements Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Equine Pharmaceuticals and Supplements Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Equine Pharmaceuticals and Supplements Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET COMPETITIVE LANDSCAPE
3.1 Global Equine Pharmaceuticals and Supplements Sales by Manufacturers (2019-2024)
3.2 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Manufacturers (2019-2024)
3.3 Equine Pharmaceuticals and Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Equine Pharmaceuticals and Supplements Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Equine Pharmaceuticals and Supplements Sales Sites, Area Served, Product Type
3.6 Equine Pharmaceuticals and Supplements Market Competitive Situation and Trends
3.6.1 Equine Pharmaceuticals and Supplements Market Concentration Rate
3.6.2 Global 5 and 10 Largest Equine Pharmaceuticals and Supplements Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 EQUINE PHARMACEUTICALS AND SUPPLEMENTS INDUSTRY CHAIN ANALYSIS
4.1 Equine Pharmaceuticals and Supplements Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2019-2024)
6.3 Global Equine Pharmaceuticals and Supplements Market Size Market Share by Type (2019-2024)
6.4 Global Equine Pharmaceuticals and Supplements Price by Type (2019-2024)
7 EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Equine Pharmaceuticals and Supplements Market Sales by Application (2019-2024)
7.3 Global Equine Pharmaceuticals and Supplements Market Size (M USD) by Application (2019-2024)
7.4 Global Equine Pharmaceuticals and Supplements Sales Growth Rate by Application (2019-2024)
8 EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET SEGMENTATION BY REGION
8.1 Global Equine Pharmaceuticals and Supplements Sales by Region
8.1.1 Global Equine Pharmaceuticals and Supplements Sales by Region
8.1.2 Global Equine Pharmaceuticals and Supplements Sales Market Share by Region
8.2 North America
8.2.1 North America Equine Pharmaceuticals and Supplements Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Equine Pharmaceuticals and Supplements Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Equine Pharmaceuticals and Supplements Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Equine Pharmaceuticals and Supplements Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Boehringer Ingelheim
9.1.1 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Basic Information
9.1.2 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Overview
9.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Market Performance
9.1.4 Boehringer Ingelheim Business Overview
9.1.5 Boehringer Ingelheim Equine Pharmaceuticals and Supplements SWOT Analysis
9.1.6 Boehringer Ingelheim Recent Developments
9.2 Merck Animal Health
9.2.1 Merck Animal Health Equine Pharmaceuticals and Supplements Basic Information
9.2.2 Merck Animal Health Equine Pharmaceuticals and Supplements Product Overview
9.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Product Market Performance
9.2.4 Merck Animal Health Business Overview
9.2.5 Merck Animal Health Equine Pharmaceuticals and Supplements SWOT Analysis
9.2.6 Merck Animal Health Recent Developments
9.3 Zoetis
9.3.1 Zoetis Equine Pharmaceuticals and Supplements Basic Information
9.3.2 Zoetis Equine Pharmaceuticals and Supplements Product Overview
9.3.3 Zoetis Equine Pharmaceuticals and Supplements Product Market Performance
9.3.4 Zoetis Equine Pharmaceuticals and Supplements SWOT Analysis
9.3.5 Zoetis Business Overview
9.3.6 Zoetis Recent Developments
9.4 Bayer Animal Health
9.4.1 Bayer Animal Health Equine Pharmaceuticals and Supplements Basic Information
9.4.2 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Overview
9.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Market Performance
9.4.4 Bayer Animal Health Business Overview
9.4.5 Bayer Animal Health Recent Developments
9.5 Elanco Animal Health
9.5.1 Elanco Animal Health Equine Pharmaceuticals and Supplements Basic Information
9.5.2 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Overview
9.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Market Performance
9.5.4 Elanco Animal Health Business Overview
9.5.5 Elanco Animal Health Recent Developments
9.6 Dechra Veterinary Products
9.6.1 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Basic Information
9.6.2 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Overview
9.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Market Performance
9.6.4 Dechra Veterinary Products Business Overview
9.6.5 Dechra Veterinary Products Recent Developments
9.7 CEVA
9.7.1 CEVA Equine Pharmaceuticals and Supplements Basic Information
9.7.2 CEVA Equine Pharmaceuticals and Supplements Product Overview
9.7.3 CEVA Equine Pharmaceuticals and Supplements Product Market Performance
9.7.4 CEVA Business Overview
9.7.5 CEVA Recent Developments
9.8 Virbac
9.8.1 Virbac Equine Pharmaceuticals and Supplements Basic Information
9.8.2 Virbac Equine Pharmaceuticals and Supplements Product Overview
9.8.3 Virbac Equine Pharmaceuticals and Supplements Product Market Performance
9.8.4 Virbac Business Overview
9.8.5 Virbac Recent Developments
9.9 Norbrook Equine
9.9.1 Norbrook Equine Equine Pharmaceuticals and Supplements Basic Information
9.9.2 Norbrook Equine Equine Pharmaceuticals and Supplements Product Overview
9.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Product Market Performance
9.9.4 Norbrook Equine Business Overview
9.9.5 Norbrook Equine Recent Developments
9.10 Kyoritsu Seiyaku
9.10.1 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Basic Information
9.10.2 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Overview
9.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Market Performance
9.10.4 Kyoritsu Seiyaku Business Overview
9.10.5 Kyoritsu Seiyaku Recent Developments
9.11 Vetoquinol
9.11.1 Vetoquinol Equine Pharmaceuticals and Supplements Basic Information
9.11.2 Vetoquinol Equine Pharmaceuticals and Supplements Product Overview
9.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Product Market Performance
9.11.4 Vetoquinol Business Overview
9.11.5 Vetoquinol Recent Developments
9.12 Protexin Healthcare
9.12.1 Protexin Healthcare Equine Pharmaceuticals and Supplements Basic Information
9.12.2 Protexin Healthcare Equine Pharmaceuticals and Supplements Product Overview
9.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Product Market Performance
9.12.4 Protexin Healthcare Business Overview
9.12.5 Protexin Healthcare Recent Developments
9.13 Audevard
9.13.1 Audevard Equine Pharmaceuticals and Supplements Basic Information
9.13.2 Audevard Equine Pharmaceuticals and Supplements Product Overview
9.13.3 Audevard Equine Pharmaceuticals and Supplements Product Market Performance
9.13.4 Audevard Business Overview
9.13.5 Audevard Recent Developments
9.14 Ouro Fino Saude
9.14.1 Ouro Fino Saude Equine Pharmaceuticals and Supplements Basic Information
9.14.2 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Overview
9.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Market Performance
9.14.4 Ouro Fino Saude Business Overview
9.14.5 Ouro Fino Saude Recent Developments
10 EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET FORECAST BY REGION
10.1 Global Equine Pharmaceuticals and Supplements Market Size Forecast
10.2 Global Equine Pharmaceuticals and Supplements Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Equine Pharmaceuticals and Supplements Market Size Forecast by Country
10.2.3 Asia Pacific Equine Pharmaceuticals and Supplements Market Size Forecast by Region
10.2.4 South America Equine Pharmaceuticals and Supplements Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Equine Pharmaceuticals and Supplements by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Equine Pharmaceuticals and Supplements Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Equine Pharmaceuticals and Supplements by Type (2025-2030)
11.1.2 Global Equine Pharmaceuticals and Supplements Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Equine Pharmaceuticals and Supplements by Type (2025-2030)
11.2 Global Equine Pharmaceuticals and Supplements Market Forecast by Application (2025-2030)
11.2.1 Global Equine Pharmaceuticals and Supplements Sales (Kilotons) Forecast by Application
11.2.2 Global Equine Pharmaceuticals and Supplements Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Equine Pharmaceuticals and Supplements Market Size Comparison by Region (M USD)
Table 5. Global Equine Pharmaceuticals and Supplements Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Equine Pharmaceuticals and Supplements Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Equine Pharmaceuticals and Supplements Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Equine Pharmaceuticals and Supplements Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Equine Pharmaceuticals and Supplements as of 2022)
Table 10. Global Market Equine Pharmaceuticals and Supplements Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Equine Pharmaceuticals and Supplements Sales Sites and Area Served
Table 12. Manufacturers Equine Pharmaceuticals and Supplements Product Type
Table 13. Global Equine Pharmaceuticals and Supplements Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Equine Pharmaceuticals and Supplements
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Equine Pharmaceuticals and Supplements Market Challenges
Table 22. Global Equine Pharmaceuticals and Supplements Sales by Type (Kilotons)
Table 23. Global Equine Pharmaceuticals and Supplements Market Size by Type (M USD)
Table 24. Global Equine Pharmaceuticals and Supplements Sales (Kilotons) by Type (2019-2024)
Table 25. Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2019-2024)
Table 26. Global Equine Pharmaceuticals and Supplements Market Size (M USD) by Type (2019-2024)
Table 27. Global Equine Pharmaceuticals and Supplements Market Size Share by Type (2019-2024)
Table 28. Global Equine Pharmaceuticals and Supplements Price (USD/Ton) by Type (2019-2024)
Table 29. Global Equine Pharmaceuticals and Supplements Sales (Kilotons) by Application
Table 30. Global Equine Pharmaceuticals and Supplements Market Size by Application
Table 31. Global Equine Pharmaceuticals and Supplements Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2019-2024)
Table 33. Global Equine Pharmaceuticals and Supplements Sales by Application (2019-2024) & (M USD)
Table 34. Global Equine Pharmaceuticals and Supplements Market Share by Application (2019-2024)
Table 35. Global Equine Pharmaceuticals and Supplements Sales Growth Rate by Application (2019-2024)
Table 36. Global Equine Pharmaceuticals and Supplements Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2019-2024)
Table 38. North America Equine Pharmaceuticals and Supplements Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Equine Pharmaceuticals and Supplements Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Equine Pharmaceuticals and Supplements Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Equine Pharmaceuticals and Supplements Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Region (2019-2024) & (Kilotons)
Table 43. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Basic Information
Table 44. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Overview
Table 45. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Boehringer Ingelheim Business Overview
Table 47. Boehringer Ingelheim Equine Pharmaceuticals and Supplements SWOT Analysis
Table 48. Boehringer Ingelheim Recent Developments
Table 49. Merck Animal Health Equine Pharmaceuticals and Supplements Basic Information
Table 50. Merck Animal Health Equine Pharmaceuticals and Supplements Product Overview
Table 51. Merck Animal Health Equine Pharmaceuticals and Supplements Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Merck Animal Health Business Overview
Table 53. Merck Animal Health Equine Pharmaceuticals and Supplements SWOT Analysis
Table 54. Merck Animal Health Recent Developments
Table 55. Zoetis Equine Pharmaceuticals and Supplements Basic Information
Table 56. Zoetis Equine Pharmaceuticals and Supplements Product Overview
Table 57. Zoetis Equine Pharmaceuticals and Supplements Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Zoetis Equine Pharmaceuticals and Supplements SWOT Analysis
Table 59. Zoetis Business Overview
Table 60. Zoetis Recent Developments
Table 61. Bayer Animal Health Equine Pharmaceuticals and Supplements Basic Information
Table 62. Bayer Animal Health Equine Pharmaceuticals and Supplements Product Overview
Table 63. Bayer Animal Health Equine Pharmaceuticals and Supplements Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Bayer Animal Health Business Overview
Table 65. Bayer Animal Health Recent Developments
Table 66. Elanco Animal Health Equine Pharmaceuticals and Supplements Basic Information
Table 67. Elanco Animal Health Equine Pharmaceuticals and Supplements Product Overview
Table 68. Elanco Animal Health Equine Pharmaceuticals and Supplements Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Elanco Animal Health Business Overview
Table 70. Elanco Animal Health Recent Developments
Table 71. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Basic Information
Table 72. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Overview
Table 73. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Dechra Veterinary Products Business Overview
Table 75. Dechra Veterinary Products Recent Developments
Table 76. CEVA Equine Pharmaceuticals and Supplements Basic Information
Table 77. CEVA Equine Pharmaceuticals and Supplements Product Overview
Table 78. CEVA Equine Pharmaceuticals and Supplements Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. CEVA Business Overview
Table 80. CEVA Recent Developments
Table 81. Virbac Equine Pharmaceuticals and Supplements Basic Information
Table 82. Virbac Equine Pharmaceuticals and Supplements Product Overview
Table 83. Virbac Equine Pharmaceuticals and Supplements Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Virbac Business Overview
Table 85. Virbac Recent Developments
Table 86. Norbrook Equine Equine Pharmaceuticals and Supplements Basic Information
Table 87. Norbrook Equine Equine Pharmaceuticals and Supplements Product Overview
Table 88. Norbrook Equine Equine Pharmaceuticals and Supplements Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Norbrook Equine Business Overview
Table 90. Norbrook Equine Recent Developments
Table 91. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Basic Information
Table 92. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Overview
Table 93. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Kyoritsu Seiyaku Business Overview
Table 95. Kyoritsu Seiyaku Recent Developments
Table 96. Vetoquinol Equine Pharmaceuticals and Supplements Basic Information
Table 97. Vetoquinol Equine Pharmaceuticals and Supplements Product Overview
Table 98. Vetoquinol Equine Pharmaceuticals and Supplements Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Vetoquinol Business Overview
Table 100. Vetoquinol Recent Developments
Table 101. Protexin Healthcare Equine Pharmaceuticals and Supplements Basic Information
Table 102. Protexin Healthcare Equine Pharmaceuticals and Supplements Product Overview
Table 103. Protexin Healthcare Equine Pharmaceuticals and Supplements Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Protexin Healthcare Business Overview
Table 105. Protexin Healthcare Recent Developments
Table 106. Audevard Equine Pharmaceuticals and Supplements Basic Information
Table 107. Audevard Equine Pharmaceuticals and Supplements Product Overview
Table 108. Audevard Equine Pharmaceuticals and Supplements Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Audevard Business Overview
Table 110. Audevard Recent Developments
Table 111. Ouro Fino Saude Equine Pharmaceuticals and Supplements Basic Information
Table 112. Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Overview
Table 113. Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Ouro Fino Saude Business Overview
Table 115. Ouro Fino Saude Recent Developments
Table 116. Global Equine Pharmaceuticals and Supplements Sales Forecast by Region (2025-2030) & (Kilotons)
Table 117. Global Equine Pharmaceuticals and Supplements Market Size Forecast by Region (2025-2030) & (M USD)
Table 118. North America Equine Pharmaceuticals and Supplements Sales Forecast by Country (2025-2030) & (Kilotons)
Table 119. North America Equine Pharmaceuticals and Supplements Market Size Forecast by Country (2025-2030) & (M USD)
Table 120. Europe Equine Pharmaceuticals and Supplements Sales Forecast by Country (2025-2030) & (Kilotons)
Table 121. Europe Equine Pharmaceuticals and Supplements Market Size Forecast by Country (2025-2030) & (M USD)
Table 122. Asia Pacific Equine Pharmaceuticals and Supplements Sales Forecast by Region (2025-2030) & (Kilotons)
Table 123. Asia Pacific Equine Pharmaceuticals and Supplements Market Size Forecast by Region (2025-2030) & (M USD)
Table 124. South America Equine Pharmaceuticals and Supplements Sales Forecast by Country (2025-2030) & (Kilotons)
Table 125. South America Equine Pharmaceuticals and Supplements Market Size Forecast by Country (2025-2030) & (M USD)
Table 126. Middle East and Africa Equine Pharmaceuticals and Supplements Consumption Forecast by Country (2025-2030) & (Units)
Table 127. Middle East and Africa Equine Pharmaceuticals and Supplements Market Size Forecast by Country (2025-2030) & (M USD)
Table 128. Global Equine Pharmaceuticals and Supplements Sales Forecast by Type (2025-2030) & (Kilotons)
Table 129. Global Equine Pharmaceuticals and Supplements Market Size Forecast by Type (2025-2030) & (M USD)
Table 130. Global Equine Pharmaceuticals and Supplements Price Forecast by Type (2025-2030) & (USD/Ton)
Table 131. Global Equine Pharmaceuticals and Supplements Sales (Kilotons) Forecast by Application (2025-2030)
Table 132. Global Equine Pharmaceuticals and Supplements Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Equine Pharmaceuticals and Supplements Market Size Comparison by Region (M USD)
Table 5. Global Equine Pharmaceuticals and Supplements Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Equine Pharmaceuticals and Supplements Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Equine Pharmaceuticals and Supplements Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Equine Pharmaceuticals and Supplements Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Equine Pharmaceuticals and Supplements as of 2022)
Table 10. Global Market Equine Pharmaceuticals and Supplements Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Equine Pharmaceuticals and Supplements Sales Sites and Area Served
Table 12. Manufacturers Equine Pharmaceuticals and Supplements Product Type
Table 13. Global Equine Pharmaceuticals and Supplements Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Equine Pharmaceuticals and Supplements
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Equine Pharmaceuticals and Supplements Market Challenges
Table 22. Global Equine Pharmaceuticals and Supplements Sales by Type (Kilotons)
Table 23. Global Equine Pharmaceuticals and Supplements Market Size by Type (M USD)
Table 24. Global Equine Pharmaceuticals and Supplements Sales (Kilotons) by Type (2019-2024)
Table 25. Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2019-2024)
Table 26. Global Equine Pharmaceuticals and Supplements Market Size (M USD) by Type (2019-2024)
Table 27. Global Equine Pharmaceuticals and Supplements Market Size Share by Type (2019-2024)
Table 28. Global Equine Pharmaceuticals and Supplements Price (USD/Ton) by Type (2019-2024)
Table 29. Global Equine Pharmaceuticals and Supplements Sales (Kilotons) by Application
Table 30. Global Equine Pharmaceuticals and Supplements Market Size by Application
Table 31. Global Equine Pharmaceuticals and Supplements Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2019-2024)
Table 33. Global Equine Pharmaceuticals and Supplements Sales by Application (2019-2024) & (M USD)
Table 34. Global Equine Pharmaceuticals and Supplements Market Share by Application (2019-2024)
Table 35. Global Equine Pharmaceuticals and Supplements Sales Growth Rate by Application (2019-2024)
Table 36. Global Equine Pharmaceuticals and Supplements Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2019-2024)
Table 38. North America Equine Pharmaceuticals and Supplements Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Equine Pharmaceuticals and Supplements Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Equine Pharmaceuticals and Supplements Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Equine Pharmaceuticals and Supplements Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Region (2019-2024) & (Kilotons)
Table 43. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Basic Information
Table 44. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Overview
Table 45. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Boehringer Ingelheim Business Overview
Table 47. Boehringer Ingelheim Equine Pharmaceuticals and Supplements SWOT Analysis
Table 48. Boehringer Ingelheim Recent Developments
Table 49. Merck Animal Health Equine Pharmaceuticals and Supplements Basic Information
Table 50. Merck Animal Health Equine Pharmaceuticals and Supplements Product Overview
Table 51. Merck Animal Health Equine Pharmaceuticals and Supplements Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Merck Animal Health Business Overview
Table 53. Merck Animal Health Equine Pharmaceuticals and Supplements SWOT Analysis
Table 54. Merck Animal Health Recent Developments
Table 55. Zoetis Equine Pharmaceuticals and Supplements Basic Information
Table 56. Zoetis Equine Pharmaceuticals and Supplements Product Overview
Table 57. Zoetis Equine Pharmaceuticals and Supplements Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Zoetis Equine Pharmaceuticals and Supplements SWOT Analysis
Table 59. Zoetis Business Overview
Table 60. Zoetis Recent Developments
Table 61. Bayer Animal Health Equine Pharmaceuticals and Supplements Basic Information
Table 62. Bayer Animal Health Equine Pharmaceuticals and Supplements Product Overview
Table 63. Bayer Animal Health Equine Pharmaceuticals and Supplements Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Bayer Animal Health Business Overview
Table 65. Bayer Animal Health Recent Developments
Table 66. Elanco Animal Health Equine Pharmaceuticals and Supplements Basic Information
Table 67. Elanco Animal Health Equine Pharmaceuticals and Supplements Product Overview
Table 68. Elanco Animal Health Equine Pharmaceuticals and Supplements Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Elanco Animal Health Business Overview
Table 70. Elanco Animal Health Recent Developments
Table 71. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Basic Information
Table 72. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Overview
Table 73. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Dechra Veterinary Products Business Overview
Table 75. Dechra Veterinary Products Recent Developments
Table 76. CEVA Equine Pharmaceuticals and Supplements Basic Information
Table 77. CEVA Equine Pharmaceuticals and Supplements Product Overview
Table 78. CEVA Equine Pharmaceuticals and Supplements Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. CEVA Business Overview
Table 80. CEVA Recent Developments
Table 81. Virbac Equine Pharmaceuticals and Supplements Basic Information
Table 82. Virbac Equine Pharmaceuticals and Supplements Product Overview
Table 83. Virbac Equine Pharmaceuticals and Supplements Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Virbac Business Overview
Table 85. Virbac Recent Developments
Table 86. Norbrook Equine Equine Pharmaceuticals and Supplements Basic Information
Table 87. Norbrook Equine Equine Pharmaceuticals and Supplements Product Overview
Table 88. Norbrook Equine Equine Pharmaceuticals and Supplements Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Norbrook Equine Business Overview
Table 90. Norbrook Equine Recent Developments
Table 91. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Basic Information
Table 92. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Overview
Table 93. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Kyoritsu Seiyaku Business Overview
Table 95. Kyoritsu Seiyaku Recent Developments
Table 96. Vetoquinol Equine Pharmaceuticals and Supplements Basic Information
Table 97. Vetoquinol Equine Pharmaceuticals and Supplements Product Overview
Table 98. Vetoquinol Equine Pharmaceuticals and Supplements Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Vetoquinol Business Overview
Table 100. Vetoquinol Recent Developments
Table 101. Protexin Healthcare Equine Pharmaceuticals and Supplements Basic Information
Table 102. Protexin Healthcare Equine Pharmaceuticals and Supplements Product Overview
Table 103. Protexin Healthcare Equine Pharmaceuticals and Supplements Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Protexin Healthcare Business Overview
Table 105. Protexin Healthcare Recent Developments
Table 106. Audevard Equine Pharmaceuticals and Supplements Basic Information
Table 107. Audevard Equine Pharmaceuticals and Supplements Product Overview
Table 108. Audevard Equine Pharmaceuticals and Supplements Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Audevard Business Overview
Table 110. Audevard Recent Developments
Table 111. Ouro Fino Saude Equine Pharmaceuticals and Supplements Basic Information
Table 112. Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Overview
Table 113. Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Ouro Fino Saude Business Overview
Table 115. Ouro Fino Saude Recent Developments
Table 116. Global Equine Pharmaceuticals and Supplements Sales Forecast by Region (2025-2030) & (Kilotons)
Table 117. Global Equine Pharmaceuticals and Supplements Market Size Forecast by Region (2025-2030) & (M USD)
Table 118. North America Equine Pharmaceuticals and Supplements Sales Forecast by Country (2025-2030) & (Kilotons)
Table 119. North America Equine Pharmaceuticals and Supplements Market Size Forecast by Country (2025-2030) & (M USD)
Table 120. Europe Equine Pharmaceuticals and Supplements Sales Forecast by Country (2025-2030) & (Kilotons)
Table 121. Europe Equine Pharmaceuticals and Supplements Market Size Forecast by Country (2025-2030) & (M USD)
Table 122. Asia Pacific Equine Pharmaceuticals and Supplements Sales Forecast by Region (2025-2030) & (Kilotons)
Table 123. Asia Pacific Equine Pharmaceuticals and Supplements Market Size Forecast by Region (2025-2030) & (M USD)
Table 124. South America Equine Pharmaceuticals and Supplements Sales Forecast by Country (2025-2030) & (Kilotons)
Table 125. South America Equine Pharmaceuticals and Supplements Market Size Forecast by Country (2025-2030) & (M USD)
Table 126. Middle East and Africa Equine Pharmaceuticals and Supplements Consumption Forecast by Country (2025-2030) & (Units)
Table 127. Middle East and Africa Equine Pharmaceuticals and Supplements Market Size Forecast by Country (2025-2030) & (M USD)
Table 128. Global Equine Pharmaceuticals and Supplements Sales Forecast by Type (2025-2030) & (Kilotons)
Table 129. Global Equine Pharmaceuticals and Supplements Market Size Forecast by Type (2025-2030) & (M USD)
Table 130. Global Equine Pharmaceuticals and Supplements Price Forecast by Type (2025-2030) & (USD/Ton)
Table 131. Global Equine Pharmaceuticals and Supplements Sales (Kilotons) Forecast by Application (2025-2030)
Table 132. Global Equine Pharmaceuticals and Supplements Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Equine Pharmaceuticals and Supplements
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Equine Pharmaceuticals and Supplements Market Size (M USD), 2019-2030
Figure 5. Global Equine Pharmaceuticals and Supplements Market Size (M USD) (2019-2030)
Figure 6. Global Equine Pharmaceuticals and Supplements Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Equine Pharmaceuticals and Supplements Market Size by Country (M USD)
Figure 11. Equine Pharmaceuticals and Supplements Sales Share by Manufacturers in 2023
Figure 12. Global Equine Pharmaceuticals and Supplements Revenue Share by Manufacturers in 2023
Figure 13. Equine Pharmaceuticals and Supplements Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Equine Pharmaceuticals and Supplements Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Equine Pharmaceuticals and Supplements Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Equine Pharmaceuticals and Supplements Market Share by Type
Figure 18. Sales Market Share of Equine Pharmaceuticals and Supplements by Type (2019-2024)
Figure 19. Sales Market Share of Equine Pharmaceuticals and Supplements by Type in 2023
Figure 20. Market Size Share of Equine Pharmaceuticals and Supplements by Type (2019-2024)
Figure 21. Market Size Market Share of Equine Pharmaceuticals and Supplements by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Equine Pharmaceuticals and Supplements Market Share by Application
Figure 24. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2019-2024)
Figure 25. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application in 2023
Figure 26. Global Equine Pharmaceuticals and Supplements Market Share by Application (2019-2024)
Figure 27. Global Equine Pharmaceuticals and Supplements Market Share by Application in 2023
Figure 28. Global Equine Pharmaceuticals and Supplements Sales Growth Rate by Application (2019-2024)
Figure 29. Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2019-2024)
Figure 30. North America Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Equine Pharmaceuticals and Supplements Sales Market Share by Country in 2023
Figure 32. U.S. Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Equine Pharmaceuticals and Supplements Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Equine Pharmaceuticals and Supplements Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Country in 2023
Figure 37. Germany Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Equine Pharmaceuticals and Supplements Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Equine Pharmaceuticals and Supplements Sales Market Share by Region in 2023
Figure 44. China Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Equine Pharmaceuticals and Supplements Sales and Growth Rate (Kilotons)
Figure 50. South America Equine Pharmaceuticals and Supplements Sales Market Share by Country in 2023
Figure 51. Brazil Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Equine Pharmaceuticals and Supplements Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Equine Pharmaceuticals and Supplements Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Equine Pharmaceuticals and Supplements Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Equine Pharmaceuticals and Supplements Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Equine Pharmaceuticals and Supplements Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Equine Pharmaceuticals and Supplements Market Share Forecast by Type (2025-2030)
Figure 65. Global Equine Pharmaceuticals and Supplements Sales Forecast by Application (2025-2030)
Figure 66. Global Equine Pharmaceuticals and Supplements Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Equine Pharmaceuticals and Supplements
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Equine Pharmaceuticals and Supplements Market Size (M USD), 2019-2030
Figure 5. Global Equine Pharmaceuticals and Supplements Market Size (M USD) (2019-2030)
Figure 6. Global Equine Pharmaceuticals and Supplements Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Equine Pharmaceuticals and Supplements Market Size by Country (M USD)
Figure 11. Equine Pharmaceuticals and Supplements Sales Share by Manufacturers in 2023
Figure 12. Global Equine Pharmaceuticals and Supplements Revenue Share by Manufacturers in 2023
Figure 13. Equine Pharmaceuticals and Supplements Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Equine Pharmaceuticals and Supplements Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Equine Pharmaceuticals and Supplements Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Equine Pharmaceuticals and Supplements Market Share by Type
Figure 18. Sales Market Share of Equine Pharmaceuticals and Supplements by Type (2019-2024)
Figure 19. Sales Market Share of Equine Pharmaceuticals and Supplements by Type in 2023
Figure 20. Market Size Share of Equine Pharmaceuticals and Supplements by Type (2019-2024)
Figure 21. Market Size Market Share of Equine Pharmaceuticals and Supplements by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Equine Pharmaceuticals and Supplements Market Share by Application
Figure 24. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2019-2024)
Figure 25. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application in 2023
Figure 26. Global Equine Pharmaceuticals and Supplements Market Share by Application (2019-2024)
Figure 27. Global Equine Pharmaceuticals and Supplements Market Share by Application in 2023
Figure 28. Global Equine Pharmaceuticals and Supplements Sales Growth Rate by Application (2019-2024)
Figure 29. Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2019-2024)
Figure 30. North America Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Equine Pharmaceuticals and Supplements Sales Market Share by Country in 2023
Figure 32. U.S. Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Equine Pharmaceuticals and Supplements Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Equine Pharmaceuticals and Supplements Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Country in 2023
Figure 37. Germany Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Equine Pharmaceuticals and Supplements Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Equine Pharmaceuticals and Supplements Sales Market Share by Region in 2023
Figure 44. China Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Equine Pharmaceuticals and Supplements Sales and Growth Rate (Kilotons)
Figure 50. South America Equine Pharmaceuticals and Supplements Sales Market Share by Country in 2023
Figure 51. Brazil Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Equine Pharmaceuticals and Supplements Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Equine Pharmaceuticals and Supplements Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Equine Pharmaceuticals and Supplements Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Equine Pharmaceuticals and Supplements Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Equine Pharmaceuticals and Supplements Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Equine Pharmaceuticals and Supplements Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Equine Pharmaceuticals and Supplements Market Share Forecast by Type (2025-2030)
Figure 65. Global Equine Pharmaceuticals and Supplements Sales Forecast by Application (2025-2030)
Figure 66. Global Equine Pharmaceuticals and Supplements Market Share Forecast by Application (2025-2030)
